Soon you will be able to spot MediTuner at Nasdax’s billboard on Times Square. All thanks to a well deserved win in the Business Challenge Sweden 2018.
MediTuner develops clinically validated digital solutions that enable asthma care for our generation! Asthma is the most common chronic diseases impacting 10% of the population – and drives enormous cost for the healthcare system. By using our tools for diagnosis and self-management of asthma – costs can be drastically reduced and patients can live an active life.